Shedding light on the Molecular Interaction Between the Hepatitis B Virus Inhibitor, Clevudine, and Human Serum Albumin: Thermodynamic, Spectroscopic, Microscopic, and In Silico Analyses

[1]  B. Salvatore,et al.  Binding Studies of AICAR and Human Serum Albumin by Spectroscopic, Theoretical, and Computational Methodologies , 2020, Molecules.

[2]  S. Mohamad,et al.  Intermolecular recognition between pyrimethamine, an antimalarial drug and human serum albumin: Spectroscopic and docking study , 2020 .

[3]  Reyhaneh Abbasi,et al.  Antiproliferative activity and human serum albumin binding propensity of [SnMe2Cl2(bu2bpy)]: multi-spectroscopic analysis, atomic force microscopy, and computational studies , 2020 .

[4]  S. Mohamad,et al.  Biophysical and in silico investigations of the molecular association between a potent RNA polymerase inhibitor, thiolutin and human serum albumin , 2020 .

[5]  Yongwook Choi,et al.  Overview of anti-Hepatitis B virus agents , 2020 .

[6]  L. Khalili,et al.  A comparative spectroscopic, surface plasmon resonance, atomic force microscopy and molecular docking studies on the interaction of plant derived conferone with serum albumins , 2019, Journal of Luminescence.

[7]  S. Farhadian,et al.  Experimental and theoretical investigations on the interaction of l-methionine molecules with α-chymotrypsin in the aqueous solution using various methods. , 2019, International journal of biological macromolecules.

[8]  Hongyu Pu,et al.  Insights into protein recognition for γ-lactone essences and the effect of side chains on interaction via microscopic, spectroscopic, and simulative technologies. , 2019, Food Chemistry.

[9]  M. Makarska-Białokoz,et al.  Study of the binding interactions between uric acid and bovine serum albumin using multiple spectroscopic techniques , 2019, Journal of Molecular Liquids.

[10]  R. H. Khan,et al.  Probing the intermolecular interactions into serum albumin and anthraquinone systems: a spectroscopic and docking approach , 2018, Journal of biomolecular structure & dynamics.

[11]  A. Petruzziello.  Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma , 2018, The open virology journal.

[12]  S. Mohamad,et al.  Biophysical and computational characterization of vandetanib-lysozyme interaction. , 2018, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[13]  Y. Panahi,et al.  Multispectral and molecular docking studies on the interaction of human serum albumin with iohexol , 2017 .

[14]  G. Budak,et al.  Seroprevalences of Hepatitis B and Hepatitis C among healthcare workers in Tire State Hospital , 2017 .

[15]  Joong-Yang Cho,et al.  Clevudine Induced Mitochondrial Myopathy , 2017, Journal of Korean medical science.

[16]  Jin Wang,et al.  Uncovering the molecular and physiological processes of anticancer leads binding human serum albumin: A physical insight into drug efficacy , 2017, PloS one.

[17]  I. Darwish,et al.  Spectrophotometric and molecular modelling studies on in vitro interaction of tyrosine kinase inhibitor linifanib with bovine serum albumin , 2017, PLoS ONE.

[18]  J. Chamani,et al.  Multi-spectroscopic and HPLC Studies of the Interaction Between Estradiol and Cyclophosphamide With Human Serum Albumin: Binary and Ternary Systems , 2016, Journal of Solution Chemistry.

[19]  Wei-Ven Tee,et al.  Binding of an anticancer drug, axitinib to human serum albumin: Fluorescence quenching and molecular docking study. , 2016, Journal of photochemistry and photobiology. B, Biology.

[20]  H. Sahoo,et al.  Interaction of Lysozyme with Rhodamine B: A combined analysis of spectroscopic & molecular docking. , 2016, Journal of photochemistry and photobiology. B, Biology.

[21]  H. Al‐Lohedan,et al.  Biophysical characterization of the interaction of bovine serum albumin with anticancer sipholane triterpenoid from the Red Sea sponge , 2016 .

[22]  Di Wu,et al.  Interaction of inosine with human serum albumin as determined by NMR relaxation data and fluorescence methodology , 2016 .

[23]  S. Mohamad,et al.  Fluorometric and molecular docking investigation on the binding characteristics of SB202190 to human serum albumin , 2016 .

[24]  S. Tayyab,et al.  Interaction of a tyrosine kinase inhibitor, vandetanib with human serum albumin as studied by fluorescence quenching and molecular docking , 2016, Journal of biomolecular structure & dynamics.

[25]  Jun Zhang,et al.  Spectroscopic study on flavonoid–drug interactions: Competitive binding for human serum albumin between three flavonoid compounds and ticagrelor, a new antiplatelet drug , 2015 .

[26]  M. Lamberti,et al.  The prevalence of hepatitis C among healthcare workers: a systematic review and meta-analysis , 2015, Occupational and Environmental Medicine.

[27]  S. Mohamad,et al.  Exploring the interaction between the antiallergic drug, tranilast and human serum albumin: Insights from calorimetric, spectroscopic and modeling studies. , 2015, International journal of pharmaceutics.

[28]  S. Mohamad,et al.  Supramolecular interaction of 6-shogaol, a therapeutic agent of Zingiber officinale with human serum albumin as elucidated by spectroscopic, calorimetric and molecular docking methods. , 2015, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[29]  Bin Liu,et al.  Spectroscopic investigation on the food components-drug interaction: the influence of flavonoids on the affinity of nifedipine to human serum albumin. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[30]  T. Khayamian,et al.  Spectroscopic, biological, and molecular modeling studies on the interactions of [Fe(III)-meloxicam] with G-quadruplex DNA and investigation of its release from bovine serum albumin (BSA) nanoparticles , 2015, Journal of biomolecular structure & dynamics.

[31]  J. Molina-Bolívar,et al.  Spectroscopic investigation on the interaction of maslinic acid with bovine serum albumin , 2014 .

[32]  O. Duman,et al.  Spectroscopic investigation of the interactions of carbofuran and amitrol herbicides with human serum albumin , 2014 .

[33]  Tinglin Huang,et al.  The interaction of plant-growth regulators with serum albumin: molecular modeling and spectroscopic methods. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[34]  J. Chamani,et al.  Determination of LMF Binding Site on a HSA-PPIX Complex in the Presence of Human Holo Transferrin from the Viewpoint of Drug Loading on Proteins , 2014, PloS one.

[35]  S. Neamţu,et al.  Spectroscopic investigation of tolmetin interaction with human serum albumin. , 2013, Journal of pharmaceutical and biomedical analysis.

[36]  F. Zsila.  Subdomain IB is the third major drug binding region of human serum albumin: toward the three-sites model. , 2013, Molecular pharmaceutics.

[37]  E. Sapi,et al.  Improved Culture Conditions for the Growth and Detection of Borrelia from Human Serum , 2013, International journal of medical sciences.

[38]  Marcus D. Hanwell,et al.  Avogadro: an advanced semantic chemical editor, visualization, and analysis platform , 2012, Journal of Cheminformatics.

[39]  L Orfi,et al.  Characterization of binding mode of imatinib to human α1-acid glycoprotein. , 2012, International journal of biological macromolecules.

[40]  M. Yuen,et al.  Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety , 2011, Current hepatitis reports.

[41]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[42]  O. K. Abou-Zied,et al.  Characterization of subdomain IIA binding site of human serum albumin in its native, unfolded, and refolded states using small molecular probes. , 2008, Journal of the American Chemical Society.

[43]  E. Murakami,et al.  Clevudine is Efficiently Phosphorylated to the Active Triphosphate form in Primary Human Hepatocytes , 2008, Antiviral therapy.

[44]  X. Yao,et al.  Studies on the binding of nevadensin to human serum albumin by molecular spectroscopy and modeling , 2007 .

[45]  N. Mateus,et al.  Interaction of different polyphenols with bovine serum albumin (BSA) and human salivary alpha-amylase (HSA) by fluorescence quenching. , 2007, Journal of agricultural and food chemistry.

[46]  Aiqin Gong,et al.  Investigation on the interaction of tetrachloride fluorescein-bovine serum albumin-beta-cyclodextrin and the determination of protein by flow injection analysis. , 2007, Analytica chimica acta.

[47]  Joong-Won Park,et al.  Twenty‐four‐week clevudine therapy showed potent and sustained antiviral activity in HBeAg‐positive chronic hepatitis B , 2007, Hepatology.

[48]  M. Otto,et al.  Clevudine: a potent inhibitor of hepatitis B virus in vitro and in vivo , 2006, Expert review of anti-infective therapy.

[49]  M. Bryszewska,et al.  Use of a Spectrofluorimetric Method to Monitor Changes of Human Serum Albumin Thermal Stability in the Presence of Polyamidoamine Dendrimers , 2006, Journal of Fluorescence.

[50]  Enzo Terreno,et al.  The extraordinary ligand binding properties of human serum albumin , 2005, IUBMB life.

[51]  N. C. Price,et al.  How to study proteins by circular dichroism. , 2005, Biochimica et biophysica acta.

[52]  R. J. Green,et al.  Interaction of flavonoids with bovine serum albumin: a fluorescence quenching study. , 2005, Journal of agricultural and food chemistry.

[53]  Hanqi Zhang,et al.  Investigation of the interaction between flavonoids and human serum albumin , 2004 .

[54]  G. Montich,et al.  Protein stability induced by ligand binding correlates with changes in protein flexibility , 2003, Protein science : a publication of the Protein Society.

[55]  Gonzalo Colmenarejo,et al.  In silico prediction of drug‐binding strengths to human serum albumin , 2003, Medicinal research reviews.

[56]  F. Zoulim,et al.  Inhibitory activity of dioxolane purine analogs on wild‐type and lamivudine‐resistant mutants of hepadnaviruses , 2002, Hepatology.

[57]  M. Otagiri,et al.  Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. , 2002, Biological & pharmaceutical bulletin.

[58]  J. Simon,et al.  Interaction of Ochratoxin A with Human Serum Albumin. Preferential Binding of the Dianion and pH Effects , 2002 .

[59]  K. Kobayashi,et al.  Crystal structure of human serum albumin at 2.5 A resolution. , 1999, Protein engineering.

[60]  G. Chang,et al.  (JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2 , 12 : 2757-2760)Reverse micelles as a model system with which to study leaving group effects on alkaline phosphatase-catalysed hydrolysis , 1997 .

[61]  P. Ross,et al.  Thermodynamics of protein association reactions: forces contributing to stability. , 1981, Biochemistry.

[62]  Y H Chen,et al.  Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion. , 1972, Biochemistry.

[63]  William R. Ware,et al.  OXYGEN QUENCHING OF FLUORESCENCE IN SOLUTION: AN EXPERIMENTAL STUDY OF THE DIFFUSION PROCESS , 1962 .